The agonist selectivity of a mouse B1 bradykinin receptor differs from human and rabbit B1 receptors

Immunopharmacology

Volumn 33, Issue 1-3, 1996, Pages 1-8

  Hess, J Fred ^a   Derrick, Amanda W ^a   MacNeil, Tanya ^a   Borkowski, Joseph A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

agonist binding; B1 receptor; mouse genomic clone

Indexed keywords

ANTIBODY; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; COMPLEMENTARY DNA; ICATIBANT; KALLIDIN; KALLIDIN[1-9]; KALLIDIN[9 LEUCINE 10 DEARGININE]; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SELECTIVITY; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; SPECIES DIFFERENCE;

EID: 0030175956     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00074-4     Document Type: Conference Paper

References (35)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of Kinins: Kallikreins, Kinintigens, and Kininases, Pharmacol Rev 1992; 44: 1-80.
2. Davis AJ, Perkins MN. Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat. Neuropharmacology 1994; 33: 127-133.
3. 9-bradykinin in vivo and in vitro. Immunopharmacology 1989; 17: 187-198.
4. 9-bradykinin and metabolically protected agonists of B1 receptors for kinins. J. Pharmacol Exp Ther 1991; 259: 997-1003.
5. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993; 16: 99-104.
6. Furuto-Kato S, Matsumoto A, Kitamura N, Nakanishi S. Primary structures of the mRNAs encoding the rat precursors for bradykinin and T-kinin. J Biol Chem 1985: 260: 12054-12059.
7. Giladi E, Spindel ER. Simple luminometric assay to detect phosphoinositol-linked receptor expression in Xenopus oocytes. BioTechniques 1991; 10: 744-747.
8. Hall JM. Bradykinin Receptors: Pharmacological properties and biological roles. Pharmacol Ther 1992; 56: 131-190.
9. Hess JF. Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 1992; 184: 260-268.
10. Hock FJ, Wirth K. Albus U, Linz W, Gerhards HJ. Wiemer G, Henke S, Breipohl G, Konig W, Knolle J, Scholkens BA. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharm 1991; 102: 769-773.
11. 9-bradykinin modulates DNA synthesis, phospholipase C and protein kinase C in cultured mesangial cells. J Biol Chem 1991; 259: 9263-9268.
12. Kozak M.J. Cell Biol 1989; 108: 229-241.
13. MacNeil T, Bierilo KK, Menke JG, Hess JF. Cloning and pharmacological characterization of a rabbit bradykinin B1 receptor. Biochim Biophys Acta 1995; 1264: 223-228.
14. Marceau F, Kinin B1 receptors: a review. Immunopharmacology 1995; 30: 1-26.
15. 2 bradykinin receptor. Proc Natl Acad Sci 1991; 88: 7724-7728.
16. McLean IW, Nakane PK. Periodate-lysine paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J Hisiochem Cytochem 1974; 22: 1077-1083.
17. Menke JG, Borkowski JA, Bierlo KK, MacNeil T, Derrick AW, Schneck KA, Ransom RW, Strader CD, Linemeyer DL, Hess JF. Expression Cloning of a Human B1 Bradykinin Receptor. J Biol Chem 1994; 269: 21583-21586.
18. Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharm Sci 1994; 15: 19-25.
19. Perkins MN, Kelly D. Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br J Pharm 1993; 110: 1441-1444.
20. 9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology 1994; 33: 657-660.
21. 8]BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain 1993; 53: 191-197.
22. Phillips E. Conder MJ, Bevan S, McIntyre P, Webb M. Expression of functional bradykinin receptors in Xenopus oocytes. J Neurochem 1992; 58: 243-249.
23. Proud D, Kaplan AP. Kinm formation: Mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988; 6: 49-83.
24. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharm Rev 1980; 32: 1-46.
25. Regoli D, Barabe J, Park WK. Receptors for bradykinin in rabbit aorta. Can J Physiol Pharm 1977; 55: 855-867.
26. Regoli D, Marceau F, Barabe J. De novo formation of vascular receptors for bradykinin. Can J Physiol Pharm 1978: 56: 674-677.
27. Regoli D, Marceau F, Lavigne J. Induction of B1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharm 1981; 71: 105-115.
28. Sandberg K, Markwick AJ, Trinh DP, Catt KJ. Calcium mobilization by angiotensin II and neurotransmitter receptors expressed in Xenopus laevis oocytes. FEBS Lett 1988; 241(1,2): 177-180.
29. Sawutz DG, Salvino JM, Dolle RE, Casiano F, Ward SJ, Houck WT. Faunce DM, Douty BD, Baizman E, Awad MMA, Marceau F, Seoane PR. The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist. Proc Natl Acad Sci 1994; 91: 4693-4697.
30. Schneck KA, Hess JF, Stonesifer GY, Ransom RW. Bradykinin B1 receptors in rabbit aorta smooth muscle cells in culture. Eur J Pharmacol 1994; 266: 277-282.
31. Sueyoshi T, Uwani M, Itoh N, Okamoto H, Muta T, Tokunaga F, Takada K, Iwanaga S. Cysteine proteinase inhibitor in the ascitic fluid of sarcoma 180 tumor-bearing mice is a low molecular weight kininogen. J Biol Chem 1990; 265: 10030-10035.
32. Tropea MM, Gummelt D, Herzig MS, Leeb-Lundberg LMF. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by Des-Arg-bradykinin and bradykinin. J Pharm Exp Ther 1993; 264: 930-937.
33. Vavrek R, Stewart JM. Competitive antagonists of bradykinin. Peptides 1985; 6: 161-164.
34. Webb M, McIntyre P, Phillips E. B1 and B2 bradykinin receptors encoded by distinct mRNAs. J Neurochem 1994; 62: 1247-1253.
35. 8]bradykinin is a potent bradykinin B1 receptor antagonist. Eur J Pharm 1991; 205: 217-218.